Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/physique/design-and-development-of-new-nanocarriers/descriptif_3778013
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3778013

Design and Development of New Nanocarriers

Langue : Anglais

Coordonnateur : Grumezescu Alexandru Mihai

Couverture de l’ouvrage Design and Development of New Nanocarriers

Design and Development of New Nanocarriers focuses on the design and development of new nanocarriers used in pharmaceutical applications that have emerged in recent years. In particular, the pharmaceutical uses of microfluidic techniques, supramolecular design of nanocapsules, smart hydrogels, polymeric micelles, exosomes and metal nanoparticles are discussed in detail. Written by a diverse group of international researchers, this book is a valuable reference resource for those working in both biomaterials science and the pharmaceutical industry.

1. Bilayer-Based Drug Carriers: Liposomes, polymersomes and niosomes 2. Recent advances in micellar-like polyelectrolyte/protein complexes: design and development of biopharmaceuticals 3. Calixarene-based micelles: properties and applications 4. Preparation of Janus Nanoparticles and its Application in Drug Delivery 5. Supramolecular design of hydrophobic and hydrophilic polymeric nanoparticles 6. Cationic Polyelectrolyte-Biopolymer Complex Hydrogel Particles for Drug Delivery 7. Smart micelleplexes: An overview of a promising and potential nanocarrier for alternative therapies 8. Polymeric Micelles as a Versatile Tool in Oral Chemotherapy 9. Mixed micelles as drug delivery nanocarriers 10. Amphiphilic block copolymers based micelles for drug delivery 11. Synthesis and evolution of polymeric nanoparticles: development of an improved gene delivery system 12. Protein and drug imprinted nanostructures as controlled delivery tools 13. Application of Complex Coacervates in Controlled Delivery 14. Hydrogels: biomedical uses 15. Development of nanocapsules derived from viral capsid proteins for medical applications 16. Layer-by-Layer coated drug-core nanoparticles as versatile delivery platforms 17. Effect of a-cyclodextrin Nanoparticles on the Structure of Iodine Complexes with Polypeptides and Alkali Metal Halogenides and on the Mechanisms of their Anti-HIV and Anti-cancer Activity 18. Nanocarriers for the delivery of Temozolomide in the treatment of Gliobastoma: A review

Pharmaceutical scientists, biomaterials scientists, toxicologists, biomedical engineers, medicinal chemists and postgraduate students specializing in the areas of nanomedicine, bionanomaterials and nanotechnology applications in healthcare.

Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books.
  • Shows how nanomanufacturing techniques can help to create more effective, cheaper pharmaceutical products
  • Explores how nanofabrication techniques developed in the lab have been translated to commercial applications in recent years
  • Explains safety and regulatory aspects of the use of nanomanufacturing processes in the pharmaceutical industry

Date de parution :

Ouvrage de 766 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

198,88 €

Ajouter au panier

Thèmes de Design and Development of New Nanocarriers :

Mots-clés :

Alkali metal halogenides; Anti-HIV drug; Antibody; Anticancer drug; Assembly; Bicomponent; Biopharmaceuticals; Biopolymers; Block copolymers; Blood-brain barrier; Calixarene micelles; Cancer drug delivery; Cancer therapy; Capsid; Cationic polymers; Characterization; Coassembly; Complex coacervation; Complexation; Complexation process; Controlled delivery; Controlled release; Core-shell; Cytotoxic T lymphocyte; Cytotoxicity; Delivery systems; Drug delivery; Drug delivery system; Drug imprinting; Drug nanocore; Encapsulation; Gene delivery; Gene silencing; Gene therapy; Glioblastoma multiform; Hydrogel nanocarriers; Hydrogel nanoparticles; Hydrogels; Hydrophilic nanoparticles; Hydrophobic drug; Hydrophobic nanoparticles; Ionic; Janus nanoparticles; Layer-by-Layer; Ligand-based delivery; Ligands in nanocarriers; Low soluble drug; Masking; Micelleplexes; Micelles; Micro; Microcapsules; Mixed micelles; Molecular imprinting; Molecular iodine complex; Nano; Nanocapsules; Nanocarriers; Nanogels; Nanomanipulation; Nanoparticle; Nanoparticle α-dextrin; Nanoparticles; Nanosystem; Nanotechnology; Natural polyelectrolytes; Nonionic; Oral chemotherapy; Peptides; Pharmaceutical nanotechnology; Phase separation; Physicochemical characteristics; Physicochemical properties; Pickering emulsion; Pluronics; Polyelectrolyte; Polyelectrolyte block copolymers; Polyelectrolyte-protein complexes; Polyelectrolytes; Polymeric micelles; Polymeric nanoparticle; Polymers; Polyomavirus; Protein imprinting; Proteins; Quantum-chemical method; Rational design; Regular solution theory; Release kinetics; Reversed; Self-assembly; Simian virus 40; Smart nanogels; Stimuli-sensitive nanogels; Stimulus-responsive; Supramolecular chemistry; Supramolecular interactions; Supramolecular self-assembly; Targeted therapy; Targeting